美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA209266"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
31722-440-01 31722-440 HUMAN PRESCRIPTION DRUG Avanafil Avanafil TABLET ORAL 20240614 N/A ANDA ANDA209266 Camber Pharmaceuticals, Inc. AVANAFIL 50 mg/1 100 TABLET in 1 BOTTLE (31722-440-01)
31722-440-30 31722-440 HUMAN PRESCRIPTION DRUG Avanafil Avanafil TABLET ORAL 20240614 N/A ANDA ANDA209266 Camber Pharmaceuticals, Inc. AVANAFIL 50 mg/1 30 TABLET in 1 BOTTLE (31722-440-30)
31722-441-01 31722-441 HUMAN PRESCRIPTION DRUG Avanafil Avanafil TABLET ORAL 20240614 N/A ANDA ANDA209266 Camber Pharmaceuticals, Inc. AVANAFIL 100 mg/1 100 TABLET in 1 BOTTLE (31722-441-01)
31722-441-30 31722-441 HUMAN PRESCRIPTION DRUG Avanafil Avanafil TABLET ORAL 20240614 N/A ANDA ANDA209266 Camber Pharmaceuticals, Inc. AVANAFIL 100 mg/1 30 TABLET in 1 BOTTLE (31722-441-30)
31722-442-01 31722-442 HUMAN PRESCRIPTION DRUG Avanafil Avanafil TABLET ORAL 20240614 N/A ANDA ANDA209266 Camber Pharmaceuticals, Inc. AVANAFIL 200 mg/1 100 TABLET in 1 BOTTLE (31722-442-01)
31722-442-30 31722-442 HUMAN PRESCRIPTION DRUG Avanafil Avanafil TABLET ORAL 20240614 N/A ANDA ANDA209266 Camber Pharmaceuticals, Inc. AVANAFIL 200 mg/1 30 TABLET in 1 BOTTLE (31722-442-30)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase